₄₃Patrick W Serruys

Key Opinion Leader In [Patrick W Serruys is considered a key opinion leader in any keyword where the rank of 5 is achieved, the leading number before the keyword shows the author's rank as compared to all other authors]

₁Sirolimus | ₁Immunosuppressive Agents | ₁Feasibility Studies | ₁Follow-Up Studies | ₁Blood Vessel Prosthesis Implantation | ₃Stents | ₃Drug Implants | ₃Coronary Vessels | ₄Coronary Restenosis | ₄Coronary Artery Disease | ₄Ultrasonography, Interventional | ₅Coronary Angiography | ₅Graft Occlusion, Vascular | ₆Treatment Outcome | ₆Recurrence | ₉Angioplasty, Transluminal, Percutaneous Coronary | ₁₃Blood Flow Velocity | ₁₆Coronary Disease | ₂₈Brachytherapy | ₃₀Postoperative Complications | ₃₅Combined Modality Therapy | ₄₀Middle Aged | ₄₇Swine | ₅₄Time Factors | ₅₅Humans | ₅₈Electrocardiography | ₇₂Male | ₁₂₉Myocardial Infarction | ₁₃₇Female | ₂₃₀Aged | ₃₅₉Risk Factors

Keywords (32) [keywords assigned to Patrick W Serruys articles by PubMed, the leading number and the color conveys importance]

₄₁Humans | ₂₆Stents | ₂₅Male | ₂₃Middle Aged | ₂₁Female | ₂₀Coronary Angiography | ₁₇Treatment Outcome | ₁₆Follow-Up Studies | ₁₅Ultrasonography, Interventional | ₁₄Coronary Vessels | ₁₂Angioplasty, Transluminal, Percutaneous Coronary | ₁₂Sirolimus | ₁₂Coronary Restenosis | ₁₂Aged | ₁₁Coronary Artery Disease | ₁₁Blood Vessel Prosthesis Implantation | ₈Immunosuppressive Agents | ₇Coronary Disease | ₇Animals | ₆Drug Implants | ₆Recurrence | ₆Time Factors | ₅Postoperative Complications | ₅Graft Occlusion, Vascular | ₅Brachytherapy | ₅Swine | ₅Myocardial Infarction | ₅Combined Modality Therapy | ₅Feasibility Studies | ₅Electrocardiography | ₅Risk Factors | ₄Blood Flow Velocity

Other [context-specific ads]

Patrick W Serruys Unique Vocabulary (96) [single words, word pairs and phrases obtained by analysis of abstracts and titles, the leading number and the color conveys importance; Patrick W Serruys might be a good expert witness on these terms]

₆₀stent | ₅₁patients | ₅₀coronary | ₃₃restenosis | ₃₁follow-up | ₃₁vulnerable | ₂₉sirolimus-eluting | ₂₈implantation | ₂₈intravascular | ₂₃in-stent | ₂₂patient | ₂₀ultrasound | ₁₉plaque | ₁₉clinical | ₁₇treatment | ₁₇stress | ₁₆ivus | ₁₆study | ₁₆shear | ₁₅stenting | ₁₅remodeling | ₁₅lesions | ₁₅wall | ₁₄group | ₁₄vessel | ₁₄stents | ₁₄conclusions | ₁₃analysis | ₁₃lumen | ₁₂angiographic | ₁₂ses | ₁₁results
₂₁sirolimus-eluting stent | ₁₇intravascular ultrasound | ₁₆stent implantation | ₁₆shear stress | ₁₃in-stent restenosis | ₁₁vulnerable plaque | ₈neointimal hyperplasia | ₈coronary arteries | ₈echolucent tissue | ₇coronary artery | ₇three-dimensional intravascular | ₆de novo | ₆intravascular elastography | ₆implantation patients | ₆major adverse | ₅acute coronary | ₅coronary syndromes | ₅left ventricular | ₅cardiac events | ₅adverse cardiac | ₅bx velocity | ₅six-month follow-up | ₄coronary lesions | ₄percutaneous coronary | ₄lumen loss | ₄sensitivity specificity | ₄ses implantation | ₄part ii | ₄direct stenting | ₃catheter-based radiation | ₃intravascular palpography | ₃late lumen
₁₀sirolimus-eluting stent implantation | ₇three-dimensional intravascular ultrasound | ₆sirolimus-eluting stent treatment | ₅acute coronary syndromes | ₅major adverse cardiac | ₅acute myocardial infarction | ₄definitions risk assessment | ₄call definitions risk | ₄intravascular ultrasound analysis | ₄vulnerable plaque vulnerable | ₄plaque vulnerable patient | ₄risk assessment strategies | ₄vulnerable patient call | ₄assessment strategies part | ₄autologous skeletal myoblasts | ₄patient call definitions | ₃late lumen loss | ₃ses implantation patients | ₃adverse cardiac events | ₃effectiveness sirolimus-eluting stent | ₃complex in-stent restenosis | ₃restenosis sirolimus-eluting stent | ₃incomplete stent apposition | ₃novo coronary lesions | ₃percutaneous left ventricular | ₃support high-risk percutaneous | ₃de novo coronary | ₃in-stent neointimal hyperplasia | ₃neointimal hyperplasia stent | ₃hyperplasia stent implantation | ₃intravascular ultrasound ivus | ₃intravascular ultrasound study

Authoratory™
•home •community •tutorial •authors •keywords •search •top ranked •login	Update 2008, Q3 Live! Excel CSV XML print ₄₃Patrick W Serruys 2002 \| 2003 \| 2004 >> Summary Social Network Interests Funding Articles Comments All Key Opinion Leader In [Patrick W Serruys is considered a key opinion leader in any keyword where the rank of 5 is achieved, the leading number before the keyword shows the author's rank as compared to all other authors] ₁Sirolimus \| ₁Immunosuppressive Agents \| ₁Feasibility Studies \| ₁Follow-Up Studies \| ₁Blood Vessel Prosthesis Implantation \| ₃Stents \| ₃Drug Implants \| ₃Coronary Vessels \| ₄Coronary Restenosis \| ₄Coronary Artery Disease \| ₄Ultrasonography, Interventional \| ₅Coronary Angiography \| ₅Graft Occlusion, Vascular \| ₆Treatment Outcome \| ₆Recurrence \| ₉Angioplasty, Transluminal, Percutaneous Coronary \| ₁₃Blood Flow Velocity \| ₁₆Coronary Disease \| ₂₈Brachytherapy \| ₃₀Postoperative Complications \| ₃₅Combined Modality Therapy \| ₄₀Middle Aged \| ₄₇Swine \| ₅₄Time Factors \| ₅₅Humans \| ₅₈Electrocardiography \| ₇₂Male \| ₁₂₉Myocardial Infarction \| ₁₃₇Female \| ₂₃₀Aged \| ₃₅₉Risk Factors Keywords (32) [keywords assigned to Patrick W Serruys articles by PubMed, the leading number and the color conveys importance] ₄₁Humans \| ₂₆Stents \| ₂₅Male \| ₂₃Middle Aged \| ₂₁Female \| ₂₀Coronary Angiography \| ₁₇Treatment Outcome \| ₁₆Follow-Up Studies \| ₁₅Ultrasonography, Interventional \| ₁₄Coronary Vessels \| ₁₂Angioplasty, Transluminal, Percutaneous Coronary \| ₁₂Sirolimus \| ₁₂Coronary Restenosis \| ₁₂Aged \| ₁₁Coronary Artery Disease \| ₁₁Blood Vessel Prosthesis Implantation \| ₈Immunosuppressive Agents \| ₇Coronary Disease \| ₇Animals \| ₆Drug Implants \| ₆Recurrence \| ₆Time Factors \| ₅Postoperative Complications \| ₅Graft Occlusion, Vascular \| ₅Brachytherapy \| ₅Swine \| ₅Myocardial Infarction \| ₅Combined Modality Therapy \| ₅Feasibility Studies \| ₅Electrocardiography \| ₅Risk Factors \| ₄Blood Flow Velocity Other [context-specific ads] Patrick W Serruys Unique Vocabulary (96) [single words, word pairs and phrases obtained by analysis of abstracts and titles, the leading number and the color conveys importance; Patrick W Serruys might be a good expert witness on these terms] ₆₀stent \| ₅₁patients \| ₅₀coronary \| ₃₃restenosis \| ₃₁follow-up \| ₃₁vulnerable \| ₂₉sirolimus-eluting \| ₂₈implantation \| ₂₈intravascular \| ₂₃in-stent \| ₂₂patient \| ₂₀ultrasound \| ₁₉plaque \| ₁₉clinical \| ₁₇treatment \| ₁₇stress \| ₁₆ivus \| ₁₆study \| ₁₆shear \| ₁₅stenting \| ₁₅remodeling \| ₁₅lesions \| ₁₅wall \| ₁₄group \| ₁₄vessel \| ₁₄stents \| ₁₄conclusions \| ₁₃analysis \| ₁₃lumen \| ₁₂angiographic \| ₁₂ses \| ₁₁results ₂₁sirolimus-eluting stent \| ₁₇intravascular ultrasound \| ₁₆stent implantation \| ₁₆shear stress \| ₁₃in-stent restenosis \| ₁₁vulnerable plaque \| ₈neointimal hyperplasia \| ₈coronary arteries \| ₈echolucent tissue \| ₇coronary artery \| ₇three-dimensional intravascular \| ₆de novo \| ₆intravascular elastography \| ₆implantation patients \| ₆major adverse \| ₅acute coronary \| ₅coronary syndromes \| ₅left ventricular \| ₅cardiac events \| ₅adverse cardiac \| ₅bx velocity \| ₅six-month follow-up \| ₄coronary lesions \| ₄percutaneous coronary \| ₄lumen loss \| ₄sensitivity specificity \| ₄ses implantation \| ₄part ii \| ₄direct stenting \| ₃catheter-based radiation \| ₃intravascular palpography \| ₃late lumen ₁₀sirolimus-eluting stent implantation \| ₇three-dimensional intravascular ultrasound \| ₆sirolimus-eluting stent treatment \| ₅acute coronary syndromes \| ₅major adverse cardiac \| ₅acute myocardial infarction \| ₄definitions risk assessment \| ₄call definitions risk \| ₄intravascular ultrasound analysis \| ₄vulnerable plaque vulnerable \| ₄plaque vulnerable patient \| ₄risk assessment strategies \| ₄vulnerable patient call \| ₄assessment strategies part \| ₄autologous skeletal myoblasts \| ₄patient call definitions \| ₃late lumen loss \| ₃ses implantation patients \| ₃adverse cardiac events \| ₃effectiveness sirolimus-eluting stent \| ₃complex in-stent restenosis \| ₃restenosis sirolimus-eluting stent \| ₃incomplete stent apposition \| ₃novo coronary lesions \| ₃percutaneous left ventricular \| ₃support high-risk percutaneous \| ₃de novo coronary \| ₃in-stent neointimal hyperplasia \| ₃neointimal hyperplasia stent \| ₃hyperplasia stent implantation \| ₃intravascular ultrasound ivus \| ₃intravascular ultrasound study

	The content of this page was generated automatically by a computer program. Copyright © 2006-2009 Authoratory.com \| All rights reserved \| Terms of use \| Privacy policy

43Patrick W Serruys

Key Opinion Leader In [Patrick W Serruys is considered a key opinion leader in any keyword where the rank of 5 is achieved, the leading number before the keyword shows the author's rank as compared to all other authors]

Keywords (32) [keywords assigned to Patrick W Serruys articles by PubMed, the leading number and the color conveys importance]

Other [context-specific ads]

Patrick W Serruys Unique Vocabulary (96) [single words, word pairs and phrases obtained by analysis of abstracts and titles, the leading number and the color conveys importance; Patrick W Serruys might be a good expert witness on these terms]

₄₃Patrick W Serruys